Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
<h4>Background</h4>At the beginning of June 2020, there were nearly 7 million reported cases of coronavirus disease 2019 (COVID-19) worldwide and over 400,000 deaths in people with COVID-19. The objective of this study was to determine associations between comorbidities listed in the Cha...
Main Authors: | Stephanie L Harrison, Elnara Fazio-Eynullayeva, Deirdre A Lane, Paula Underhill, Gregory Y H Lip |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-09-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1003321 |
Similar Items
-
Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
by: Stephanie L. Harrison, et al.
Published: (2021-02-01) -
Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
by: Benjamin J. R. Buckley, et al.
Published: (2021-06-01) -
Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
by: Benjamin J. R. Buckley, et al.
Published: (2021-12-01) -
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
by: José Miguel Rivera-Caravaca, et al.
Published: (2021-09-01) -
Cloning and characterization of genes involved in nostoxanthin biosynthesis of Sphingomonas elodea ATCC 31461.
by: Liang Zhu, et al.
Published: (2012-01-01)